Healthcare Sales & Marketing Network News: OSA

Searching News Database: OSA

HSMN NewsFeed - 9 Jul 2025
Neuros Medical Secures $56M Series D to Commercialize the Altius(R) System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputation Pain
Devices Venture Capital

HSMN NewsFeed - 4 Apr 2025
Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 20 Mar 2025
Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia & Gulf Countries
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2024
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Apr 2024
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS(R) (edaravone)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 12 Oct 2023
Centinel Spine Surgical Stadium Event at NASS 2023 to Demonstrate Value of prodisc(R) Match-the-Disc(TM) Cervical and Lumbar Total Disc Replacement Systems
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 8 Jun 2023
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Regenerative Medicine Venture Capital

HSMN NewsFeed - 31 May 2023
Excellent 12-Month Results from SELUTION SFA Trial Presented at JET
Devices Interventional

HSMN NewsFeed - 1 Mar 2023
Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology and Expand Pipeline of Durable Precision Genomic Medicines
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Jun 2022
MicroTransponder Raises $53M, Appoints New CEO
Devices Neurology Personnel Venture Capital

HSMN NewsFeed - 15 Jun 2022
RADICAVA ORS(R) (edaravone) Now Available in the U.S. for the Treatment of ALS
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 5 May 2022
XII Medical Completes $30 Million Series A Financing
Devices Venture Capital

HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 30 Jun 2021
Mitsubishi Tanabe Pharma America Announces EXSERVAN(TM) (riluzole) is Now Available in the U.S. for the Treatment of ALS
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 18 May 2021
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Apr 2021
Mineralys Therapeutics Closes $40 Million Series A Funding
Biopharmaceuticals Cardiology Venture Capital Personnel

HSMN NewsFeed - 11 Feb 2021
Cyteir Therapeutics Secures $80 Million in Series C Financing to Advance Clinical Trials of Lead RAD51 Program
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 28 Jan 2021
Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate
Biopharmaceuticals Licensing

HSMN NewsFeed - 24 Nov 2020
Signifier Medical Technologies appoints Alastair Maxwell as Chief Financial Officer
Devices Personnel

HSMN NewsFeed - 29 Oct 2020
Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical Stage Research in Therapeutics Designed to Restore Immune Homeostasis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Oct 2020
Signifier Medical Technologies appoints Travis Nieman as Managing Director International
Devices Personnel

HSMN NewsFeed - 22 Sep 2020
MicroVention-Terumo Announces New Leadership
Devices Interventional Personnel

HSMN NewsFeed - 17 Sep 2020
Accuray Radixact(R) System with Synchrony(R) Technology Delivers Advanced Cancer Treatments at Multiple Hospitals in Japan
Devices Oncology

HSMN NewsFeed - 16 Sep 2020
Signifier Medical Technologies Closes $10M Series C Funding Round
Devices Venture Capital

HSMN NewsFeed - 30 Mar 2020
OssDsign Receives Regulatory Approval and Prepares for Launch in Japan
Devices Orthopaedic Regulatory Distribution

HSMN NewsFeed - 23 Dec 2019
TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE's generic division, Pensa Investments
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 15 Nov 2019
Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Oct 2019
Cyteir Therapeutics Secures Additional $40.2 Million in Its Series B Financing and Doses First Patient in Phase 1/2 Study of First-in-Class RAD51 Inhibitor
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 27 Aug 2019
PIONYR Immunotherapeutics Announces Key Leadership Team Addition and Clinical Candidates Targeting Tumor-Associated Macrophages
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Apr 2019
Satsuma Pharmaceuticals Raises $62 Million in Series B Preferred Stock Financing
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 28 Mar 2019
Hyalex Orthopaedics, synthetic cartilage company, adds new funding; expanding Series A total to $33MM
Devices Orthopaedic Venture Capital Personnel

HSMN NewsFeed - 9 Nov 2018
Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Jun 2018
FDA Authorizes FRESCA Medical To Market New Positive Airway Pressure Delivery System To Treat Sleep Apnea
Devices FDA

HSMN NewsFeed - 21 May 2018
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
Devices Interventional Radiology Neurology FDA

HSMN NewsFeed - 30 Apr 2018
Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin(TM) Cytokines
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 20 Apr 2018
Hill-Rom Enhances Spot(TM) Vision Screener To Serve Senior Population
Devices Ophthalmology Product Launch

HSMN NewsFeed - 19 Mar 2018
PMV Pharma Appoints Salim Yazji, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 2 Mar 2018
Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Dec 2017
Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Dec 2017
PMV Pharma Appoints Winston Kung as COO & CFO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 Nov 2017
Mitsubishi Tanabe Pharma America Announces Addition of RADICAVA(R) (edaravone) to U.S. Department of Veterans Affairs National Formulary
Biopharmaceuticals Neurology Reimbursement

HSMN NewsFeed - 21 Nov 2017
Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda(R) (Lurasidone Hydrochloride) in Europe
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 9 Nov 2017
Stryker Receives US FDA HDE Approval ror the Neuroform Atlas(TM) Stent System to Treat Wide Neck Aneurysms
Devices Interventional FDA

HSMN NewsFeed - 9 Nov 2017
Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Aug 2017
First FDA-Approved Treatment For ALS In 22 Years Now Available In U.S.
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 12 Jul 2017
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
Biopharmaceutical Neurology Venture Capital

HSMN NewsFeed - 23 Jun 2017
Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix(R) (vortioxetine) sNDA
Biopharmaceuticals FDA

HSMN NewsFeed - 31 May 2017
Hyalex Orthopaedics Raises $16 Million Series A Financing and Appoints Chief Executive Officer
Devices Orthopaedic Venture Capital Personnel

HSMN NewsFeed - 31 May 2017
Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 9 May 2017
Takeda and GammaDelta Therapeutics Announce Collaboration to Advance Tissue-derived gamma delta (γδ) T Cells
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Apr 2017
Japan's Sawai Pharmaceutical to Acquire the Generics Business of U.S. Upsher-Smith Laboratories
Biopharmaceuticals Generics Acquisitions

HSMN NewsFeed - 11 Apr 2017
Philips Simplifies Travel for Sleep Apnea Patients with New Compact and Connected Dreamstation Go Sleep Therapy Device
Devices Product Launch

HSMN NewsFeed - 28 Mar 2017
Antiva Biosciences Closes $22 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 8 Mar 2017
Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Feb 2017
Corindus Vascular Robotics Announces Strategic Distribution Partnership with MC Healthcare Group Granting Exclusive Rights to Distribute the CorPath(R) GRX System in Japan
Devices Interventional Distribution

HSMN NewsFeed - 5 Dec 2016
KYOCERA Medical Corporation Receives FDA 510(k) Clearance for Initia(R) Total Hip System, Featuring BIOCERAM AZUL(R) Ceramic Femoral Head
Devices Orthopaedic FDA

HSMN NewsFeed - 28 Nov 2016
Conditional Approval from the European Commission to Treat Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 16 Nov 2016
Millar, Inc. Announces Clinical Distribution Agreement with Taisho Biomed Instruments Co., Ltd.
Devices Cardiology Monitoring Distribution

HSMN NewsFeed - 10 Nov 2016
Bristol-Myers Squibb Signs Exclusive Worldwide License Agreement with Nitto Denko for Targeted siRNA Therapy in Advanced Non-alcoholic Steatohepatitis (NASH) and Cirrhosis Due to NASH
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Aug 2016
Takeda Receives Marketing Authorization in Canada for NINLARO(TM) (ixazomib) in Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 10 May 2016
Aptinyx Raises $65 Million in Series A Financing to Advance Therapies for Neurological Disorders
Biopharmaceuticals Neurology Venture Capital Personnel

HSMN NewsFeed - 17 Mar 2016
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 15 Mar 2016
Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 19 Feb 2016
Nipro Medical Corporation Launches the Cronus(TM) HP 0.035" OTW PTA Balloon Catheter in the United States
Devices Interventional Product Launch

HSMN NewsFeed - 18 Feb 2016
Nipro Medical Corporation Launches the AQUALiner II Second Generation 0.035" Hydrophilic, Super-Elastic Nitinol Guidewire in the United States
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 11 Jan 2016
Iconic Therapeutics Closes Series C Financing With New and Existing Investors
Biopharmaceuticals Oncology Ophthalmology Venture Capital

HSMN NewsFeed - 22 Dec 2015
eFFECTOR Therapeutics Raises $40 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 30 Nov 2015
Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan
Biopharmaceuticals Generics

HSMN NewsFeed - 2 Nov 2015
Bristol-Myers Squibb to Acquire Cardioxyl Pharmaceuticals, Inc.
Biopharmaceuticals Cardiology Mergers & Acquisitions

HSMN NewsFeed - 23 Oct 2015
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX(TM) - First Low Dose SoluMatrix(R) Meloxicam for Osteoarthritis Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Sep 2015
Selecta Announces $38 Million Series E Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Jul 2015
Takatsuki General Hospital Performs First Procedure With Stereotaxis Niobe(R) ES Technology in Japan
Devices Cardiology

HSMN NewsFeed - 6 Jul 2015
Strensiq(R) (asfotase alfa) Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia (HPP)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Apr 2015
Iroko Pharmaceuticals Appoints New Member to Company’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Feb 2015
Nakashima and Teijin to Establish Joint Venture for Global Expansion of Japanese-made Medical Device Business
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 19 Feb 2015
Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Nov 2014
ImThera Medical, Inc. Receives FDA Approval for Pivotal Study for Obstructive Sleep Apnea Device
Devices FDA

HSMN NewsFeed - 19 Jun 2014
Takeda Announces Termination of Orteronel (TAK-700) Development for Prostate Cancer in Japan, U.S.A. and Europe
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 May 2014
FDA Approves Inspire(R) Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea
Devices FDA

HSMN NewsFeed - 7 Apr 2014
Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Mar 2014
Kolltan Pharmaceuticals Obtains $60 Million in Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Feb 2014
Iroko Pharmaceuticals Makes Strategic Additions to the Company’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jan 2014
Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 9 Jan 2014
Akorn Acquires Betimol(R) from Santen
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 19 Dec 2013
Takeda Announces Exclusive License and Option Agreement with Natrogen for Development of Natura-alpha for Inflammatory Bowel Disease
Biopharmaceuticals Gastroenterology Licensing

HSMN NewsFeed - 18 Dec 2013
Takeda Launches New Subsidiary in Israel
Biopharmaceuticals

HSMN NewsFeed - 9 Dec 2013
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 30 Oct 2013
Immune Design Raises Up to $49 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 22 Oct 2013
Sideris Pharmaceuticals Completes $32 Million Equity Financing and Signs Agreement With Global Pharmaceutical Company
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 11 Sep 2013
Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Sep 2013
Otonomy Completes $45.9 Million Series C Equity Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 12 Aug 2013
Symetis Announces Successful, First Time Implantation of Its ACURATE TA(TM) and ACURATE TF(TM) TAVI Systems in Japan
Devices Interventional Cardiology

HSMN NewsFeed - 30 May 2013
Breathe Technologies Sleep System Receives FDA Clearance
Devices FDA

HSMN NewsFeed - 20 May 2013
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 9 Apr 2013
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 10 Dec 2012
ApniCure Appoints David P. White, M.D., as Chief Scientific Officer
Devices Personnel

HSMN NewsFeed - 4 Dec 2012
Sorin Group Receives PMDA Approval and Announces Commercial Launch of the Mitroflow(R) Aortic Pericardial Heart Valve in Japan
Devices Cardiology Regulatory

HSMN NewsFeed - 19 Nov 2012
AGTC Secures $37.5M Series B Funding
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 6 Nov 2012
Takeda to Acquire Envoy Therapeutics, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 31 Oct 2012
Takeda and Millennium Announce European Conditional Marketing Authorization for ADCETRIS(R) (Brentuximab Vedotin)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 24 Oct 2012
Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 4 Oct 2012
Volcano Announces CE Mark and 510(k) Clearance for New Visions(R) PV .035 Digital IVUS Catheter
Devices Interventional Cardiology FDA

HSMN NewsFeed - 13 Sep 2012
Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom
Biopharmaceuticals Licensing

HSMN NewsFeed - 4 Sep 2012
Revestive(R) (teduglutide) Receives European Marketing Authorization for the Treatment of Adults with Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 25 Jun 2012
FDA Approves enVista(TM), a Single-Piece Intraocular Lens, Made From the Glistening-Free, Hydrophobic, Acrylic Material Developed by AVS
Devices Ophthalmology FDA

HSMN NewsFeed - 22 Jun 2012
Takeda Receives Positive CHMP Opinion for Teduglutide (Revestive(R)) for Patients with Short Bowel Syndrome
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 20 Jun 2012
Bausch & Lomb Receives FDA Approval of the enVista(TM) Intraocular Lens
Devices Ophthalmology FDA

HSMN NewsFeed - 5 Jun 2012
Ceptaris Secures $10 Million in Series D-1 Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 May 2012
Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 May 2012
ApniCure Receives FDA 510(k) Clearance to Market Winx(TM) Sleep Therapy System for Treatment of Obstructive Sleep Apnea
Devices FDA

HSMN NewsFeed - 11 May 2012
Takeda Announces GEMINI II Trial of Vedolizumab in Patients with Moderately to Severely Active Crohn’s Disease Met Primary Endpoints of Improvement in Clinical Remission in Induction and Maintenance Phases
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 11 Apr 2012
Takeda to Acquire URL Pharma
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Apr 2012
Par Pharmaceutical Begins Shipment of Generic Provigil(R)
Biopharmaceuticals Generics

HSMN NewsFeed - 21 Feb 2012
Ceptaris Secures $15M in Venture Debt Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 18 Jan 2012
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
Biopharmaceuticals

HSMN NewsFeed - 13 Dec 2011
Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery
Biopharmaceuticals

HSMN NewsFeed - 18 Nov 2011
Shire Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd.
Biopharmaceuticals

HSMN NewsFeed - 15 Nov 2011
Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfield, MD as Chief Executive Officer
Diagnostics Venture Capital Personnel

HSMN NewsFeed - 3 Nov 2011
Tangent Medical Closes $4.5 Million Series A Financing
Devices Venture Capital Personnel

HSMN NewsFeed - 2 Nov 2011
Medtronic Begins Transcatheter Aortic Valve Trial in Japan
Devices Interventional Cardiology

HSMN NewsFeed - 1 Nov 2011
FDA Approves Addition of Sustained Overall Survival Advantage (5-year follow-up) to Label for VELCADE(R) in Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Oct 2011
Ventus Medical Launches Provent(R) Sleep Apnea Therapy in Australia and New Zealand
Devices

HSMN NewsFeed - 30 Sep 2011
Takeda Completes Acquisition and Names New CEO of Nycomed
Biopharmaceuticals Personnel Mergers & Acquisitions

HSMN NewsFeed - 21 Jun 2011
St. Jude Medical Announces Japanese Launch of Smaller, Higher Power ICD and CRT-D Devices
Devices Cardiology Regulatory

HSMN NewsFeed - 13 Jun 2011
Cytochroma Announces New Appointments to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2011
Takeda to Acquire Nycomed
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 May 2011
Teijin Pharma to Launch Feburic(r) (febuxostat) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Apr 2011
Shionogi Announces New US Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Mar 2011
Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 4 Mar 2011
Volcano Announces the Introduction of the Eagle Eye(R) Platinum Digital IVUS Catheter at the 20th PCI Live Demonstration Course in Kurashiki
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 1 Feb 2011
FDA Issues Complete Response to New Drug Application for Contrave(R) for the Management of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Dec 2010
Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Dec 2010
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Dec 2010
Orexigen(R) Therapeutics' Investigational Drug Contrave(R) Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Biopharmaceuticals Licensing

HSMN NewsFeed - 30 Nov 2010
Inspire Medical Systems Announces FDA approval for Pivotal Clinical Trial
Devices Neurology FDA

HSMN NewsFeed - 15 Nov 2010
Breathe Technologies Appoints New CEO
Devices Personnel

HSMN NewsFeed - 15 Oct 2010
On-X Life Technologies Appoints Senko Exclusive Distributor of the On-X Heart Valve in Japan
Devices Cardiology Distribution

HSMN NewsFeed - 23 Sep 2010
Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 7 Sep 2010
BARRX Medical Signs Distribution Agreement With Medico's Hirata for Exclusive Distribution of the HALO Radiofrequency Ablation System in Japan
Devices Gastroenterology Distribution

HSMN NewsFeed - 29 Jul 2010
Shionogi Inc. Announces FDA Approval of CUVPOSA for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Jul 2010
Sepracor Inc. to Become Sunovion Pharmaceuticals Inc.
Biopharmaceuticals

HSMN NewsFeed - 1 Jul 2010
Shionogi Announces Reorganization of US Operations, New Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jun 2010
Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer
Devices Neurology Personnel

HSMN NewsFeed - 10 May 2010
Takeda to Co-Promote VELCADE(R) (bortezomib) for Injection in Japan
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Apr 2010
Takeda Provides Update on Patent Litigation for ACTOS(R) (pioglitazone HCl) and ACTOplus met(R) (pioglitazone HCl and metformin HCl) in the U.S.
Biopharmaceuticals Litigation Endocrinology

HSMN NewsFeed - 16 Apr 2010
Alexion's Soliris(R) (Eculizumab) Receives Marketing Approval in Japan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Apr 2010
Carl Zeiss Meditec Introduces the First Femtosecond-Only Laser Vision Correction Procedure at the American Society of Cataract and Refractive Surgery Meeting
Devices Ophthalmology

HSMN NewsFeed - 1 Apr 2010
AMAG Pharmaceuticals and Takeda Pharmaceutical Company Announce Strategic Collaboration for Feraheme(R) in All Therapeutic Indications in Select Ex-US Territories, Including Europe
Biopharmaceuticals Licensing

HSMN NewsFeed - 22 Feb 2010
Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2010
ResMed Introduces Next-Generation CPAP Series in Europe
Devices

HSMN NewsFeed - 21 Jan 2010
Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unit
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Dec 2009
Seattle Genetics and Millennium: The Takeda Oncology Company Announce Strategic Collaboration for Novel Late-Stage Lymphoma Program Brentuximab Vedotin (SGN-35)
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Dec 2009
Apnex Medical, Inc. Raises Additional $14 Million
Devices Venture Capital

HSMN NewsFeed - 3 Dec 2009
Nasal-Aire(R) II Petite Receives FDA 510(k) Clearance for Pediatric Use
Devices FDA

HSMN NewsFeed - 6 Nov 2009
First Transcatheter Valve Cases in Japan Performed With Edwards SAPIEN Valve
Devices Interventional Cardiology

HSMN NewsFeed - 2 Oct 2009
Arginetix Closes $10.75 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Sep 2009
ImThera Medical Completes Development of Targeted Hypoglossal Neurostimulation Treatment for OSA
Devices

HSMN NewsFeed - 29 Jul 2009
Sciele Pharma and Plethora Solutions Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation
Biopharmaceuticals

HSMN NewsFeed - 10 Jul 2009
Sciele Pharma, a Shionogi Company, Terminates Agreement to Acquire Victory Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Jun 2009
Inspire Medical Systems Completes $17 Million Series B Financing
Devices Venture Capital

HSMN NewsFeed - 18 May 2009
Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 13 May 2009
FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 5 May 2009
Takeda Global Research & Development Center, Inc., U.S. Names Dr. Azmi Nabulsi President
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 May 2009
Merck Serono Launches Glucophage Powder in First European Countries
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 22 Apr 2009
MediciNova Reports Final Data from Phase II MN-221 Emergency Department Clinical Trial (MN-221-CL-006); Hospitalization Rates Decrease 45 Percent With MN-221 Plus Standardized Care in Asthma Patients
Biopharmaceuticals

HSMN NewsFeed - 9 Apr 2009
Ventus Medical Appoints John McCutcheon as President and CEO
Devices Personnel

HSMN NewsFeed - 30 Mar 2009
First-of-its-Kind Natural Orifice Surgical Procedure Performed Using Power Medical Interventions(r) Intelligent Surgical Instruments(tm)
Devices Surgery

HSMN NewsFeed - 11 Mar 2009
Shire Announces Launch of FOSRENOL(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Feb 2009
Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation
Diagnostics Acquisitions

HSMN NewsFeed - 26 Feb 2009
Inspire Medical Systems Completes First Implant of the Inspire II System to Treat Obstructive Sleep Apnea
Devices

HSMN NewsFeed - 14 Feb 2009
FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
Biopharmaceuticals FDA

HSMN NewsFeed - 31 Jan 2009
FDA Approves KAPIDEX(TM) (Dexlansoprazole) Delayed Release Capsules for the Treatment of GERD
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 14 Jan 2009
St. Jude Medical Announces Japanese Approval of Atlas II ICD
Devices Cardiology Regulatory

HSMN NewsFeed - 23 Dec 2008
MediciNova Proposes to Acquire Avigen, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Sep 2008
TeraRecon Advances in Cardiac Imaging With Aquarius iNtuition(TM) at ASNC 2008
Devices Cardiology Radiology

HSMN NewsFeed - 8 Sep 2008
MediciNova to Present At Merriman Curhan Ford's 5th Annual Investor Summit 2008
Biopharmaceuticals

HSMN NewsFeed - 2 Sep 2008
Sucampo Pharmaceuticals Limited Appoints New Head of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Aug 2008
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jun 2008
Gore Receives Approval to Market GORE TAG(R) Thoracic Endoprosthesis in Japan
Devices Interventional Regulatory

HSMN NewsFeed - 5 Jun 2008
Covidien Launches Sandman Info(TM) and Sandman Auto(TM) CPAP Devices in the United States
Devices

HSMN NewsFeed - 27 May 2008
AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 27 May 2008
Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 14 May 2008
Takeda Completes Acquisition of Millennium
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 May 2008
Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 May 2008
Abbott, Takeda Conclude TAP Joint Venture
Biopharmaceuticals

HSMN NewsFeed - 29 Apr 2008
Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Apr 2008
Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Apr 2008
TeraRecon Founds German Subsidiary and Establishes European Headquarters
Devices

HSMN NewsFeed - 10 Apr 2008
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Apr 2008
Kyocera Resumes U.S. Sales of Ceramic Orthopedic Implant Components
Devices Orthopaedic

HSMN NewsFeed - 8 Apr 2008
First Commercial Procedures Performed in Japan with Endologix Powerlink System
Devices Interventional

HSMN NewsFeed - 31 Mar 2008
Naglazyme Approved by Japanese Ministry of Health
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 Mar 2008
Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 19 Mar 2008
Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
Biopharmaceuticals

HSMN NewsFeed - 27 Feb 2008
Sucampo Pharma Europe Announces the Filing of a Marketing Authorisation Application of Lubiprostone in the United Kingdom with Eight Additional European Countries to Follow
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Feb 2008
Sucampo Pharmaceuticals Appoints John C. Wright, Retired Ernst & Young Partner, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Feb 2008
Covidien Introduces Sandman Intro(TM) CPAP Device
Devices

HSMN NewsFeed - 4 Feb 2008
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
Biopharmaceuticals Licensing

HSMN NewsFeed - 1 Feb 2008
MediciNova's MN-166 Reduces Persistent Black Hole Formation in Multiple Sclerosis Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 30 Jan 2008
Iroko Pharmaceuticals Acquires Rights to Cardiovascular Product from Merck & Co., Inc.
Biopharmaceuticals Cardiology Acquisitions

HSMN NewsFeed - 28 Jan 2008
Pfizer Japan Receives Manufacturing and Marketing Authorization for Champix(R)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Dec 2007
Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
Devices Mergers & Acquisitions

HSMN NewsFeed - 26 Nov 2007
TeraRecon Appoints New President
Devices Radiology Personnel

HSMN NewsFeed - 19 Nov 2007
Meyer Pharmaceuticals Acquires NF-kappaB Decoy Technology for Treatment of Inflammatory Disease
Biopharmaceuticals Dermatology Licensing

HSMN NewsFeed - 30 Oct 2007
Abaxis Announces Appointment of New Distribution Partner in Japan
Diagnostics Distribution

HSMN NewsFeed - 9 Oct 2007
Cutera Expands International Distribution and Opens Second Office in Japan
Devices Dermatology

HSMN NewsFeed - 18 Sep 2007
New U.S. Multi-Center Clinical Study Affirms Efficacy and Benefit of Restore Medical's Pillar(R) Procedure
Devices

HSMN NewsFeed - 4 Sep 2007
Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Aug 2007
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 1 Aug 2007
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
Biopharmaceuticals HIV/AIDS Venture Capital Personnel

HSMN NewsFeed - 16 Jul 2007
Hanger Orthopedic Group, Inc. Announces a Commercialization Agreement Between Its Subsidiary, Innovative Neurotronics, and Teijin Limited for the WalkAide System in the Japanese Market
Devices Licensing

HSMN NewsFeed - 26 Jun 2007
MediciNova Announces New Strategic Initiative
Biopharmaceuticals

HSMN NewsFeed - 18 Jun 2007
Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Jun 2007
GE Healthcare Demonstrates Innovative Research Advancements for Next-Generation CT Imaging
Devices Radiology

HSMN NewsFeed - 11 Jun 2007
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 30 May 2007
Teleflex Medical Launches Bravo Nasal Pillow CPAP Mask
Devices

HSMN NewsFeed - 22 May 2007
Aspire Medical Announces First Implant in US and Start of Clinical Trial to Treat Sleep Apnea
Devices

HSMN NewsFeed - 1 May 2007
Aspire Medical Appoints Roseanne Varner as President and CEO
Devices Personnel

HSMN NewsFeed - 27 Apr 2007
CHMP Adopts Negative Opinion on Genasense(R) Application in Melanoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Apr 2007
TeraRecon Appoints Jeff Sorenson as Vice President of Aquarius Sales, USA and Canada
Devices Radiology Personnel

HSMN NewsFeed - 18 Apr 2007
Iroko Pharmaceuticals Appoints John Vavricka as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2007
Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Mar 2007
MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 26 Mar 2007
Iroko Pharmaceuticals Acquires Rights to Two Pharmaceutical Products from Merck & Co., Inc.
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 12 Mar 2007
Takeda to Acquire Paradigm Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Mar 2007
New Hybrid(TM) CPAP Mask Emerging as a Strong Alternative to C-Flex/EPR and Bi-level Machines
Devices

HSMN NewsFeed - 26 Feb 2007
Takeda and TAP to Promote Sucampo's AMITIZA(R) in the United States
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 5 Feb 2007
Bioenvision Appoints General Manager in Japan
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jan 2007
EDAP TMS S.A. Announces Exclusive Distribution of New Muscle Trainer Device in Japan
Devices Interventional

HSMN NewsFeed - 19 Dec 2006
Wisconsin Physician Services Now Covers Restore Medical's Pillar(R) Palatal Implant System for Obstructive Sleep Apnea
Devices Reimbursement

HSMN NewsFeed - 7 Dec 2006
Cephalon Provides Update Related to Final NUVIGIL(TM) Labeling
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Nov 2006
Pharmion Acquires Cabrellis Pharmaceuticals, Gains Rights to Amrubicin for North America and the European Union
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 13 Nov 2006
Yaupon Therapeutics Closes $4 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Nov 2006
MediciNova Appoints Shintaro Asako as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Nov 2006
MediciNova Announces the Acquisition of Two Novel Antithrombotic Agents from Meiji Seika Kaisha, Ltd.
Biopharmaceuticals Cardiology Acquisitions

HSMN NewsFeed - 26 Oct 2006
Sapphire Therapeutics, Inc. Licenses Novel Drug to Ono Pharmaceuticals in Japan, Korea and Taiwan for the Treatment of Cancer Anorexia/Cachexia
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 5 Oct 2006
Tracy Lawhon, J.D., Joins Cabrellis Pharmaceuticals as Vice President, Regulatory Affairs and Development Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Oct 2006
Six New Studies Document Efficacy and Sustained Benefit of Restore Medical's Pillar(R) Procedure
Devices

HSMN NewsFeed - 2 Oct 2006
Xenon and Takeda Announce Agreement To Develop and Commercialize XEN401 for Pain in Japan and Certain Asian Countries
Biopharmaceuticals

HSMN NewsFeed - 29 Sep 2006
TAP Enters Into Co-Promotion Agreement for Famvir(R)
Biopharmaceuticals

HSMN NewsFeed - 14 Sep 2006
Sara Zaknoen, M.D., Joins Cabrellis Pharmaceuticals as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Sep 2006
Health Canada Approves Restore Medical's Pillar(R) Palatal Implant System
Devices Regulatory

HSMN NewsFeed - 17 May 2006
Cabrellis Pharmaceuticals Corporation Announces Corporate Launch and Founding Management Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 May 2006
Response Biomedical and Shionogi Finalize Commercialization Agreement For RAMP Cardiovascular Testing in Japan
Diagnostics Cardiology

Return to NewsFeed

Additional items found! 119

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 119 additional stories matching:
OSA
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!